Preliminary research published in Nature suggests that COVID-19 vaccines, particularly Pfizer and Moderna, may offer unexpected benefits for cancer patients. People with advanced lung or skin cancer who received the vaccine within 100 days of starting immunotherapy lived significantly longer. Researchers found that the mRNA in the vaccines might enhance the immune system’s response to cancer treatments, independent of any virus-related effects.
Trending
- Can ‘middle powers’ come together to build a new economic alliance? | European Union News
- ‘Weird and icky’: Would Australians support a smart glasses ban?
- My evil dad raped me in blind rage – then I was sick & horror reality dawned… mum’s reaction made it so much worse
- Ebola outbreak reaches new areas in Democratic Republic of Congo
- Torres strikes again as PSG beat bitter rivals Marseille
- Germany’s Alexander Zverev wins US Open
- Cate Blanchett chastises theater audience for filming her London play: ‘It spoils it’
- 'Subtle changes pointing to consumer fatigue' a challenge for fast-fashion retailers, expert says
